Long-Term Efficacy and Safety of Fostemsavir among Subgroups of Heavily Treatment-Experienced Adults with HIV-1
Peter Ackerman
(1)
,
Melanie Thompson
,
Jean-Michel Molina
(2)
,
Judith Aberg
(3)
,
Isabel Cassetti
,
Michael Kozal
(4)
,
Antonella Castagna
(5)
,
Marcelo Martins
,
Moti Ramgopal
,
Eduardo Sprinz
,
Sandra Treviño-Pérez
,
Adrian Streinu-Cercel
,
Gulam H. Latiff
,
Gilles Pialoux
(6, 7)
,
Princy N. Kumar
,
Marcia Wang
(8)
,
Shiven Chabria
(1)
,
Amy Pierce
(1)
,
Cyril Llamoso
(1)
,
Max Lataillade
(1)
1
ViiV Healthcare US
2 AP-HP - Hopital Saint-Louis [AP-HP]
3 MSSM - Icahn School of Medicine at Mount Sinai [New York]
4 YSM - Yale School of Medicine [New Haven, Connecticut]
5 IRCCS Ospedale San Raffaele [Milan, Italy]
6 CHU Tenon [AP-HP]
7 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
8 GSK - GlaxoSmithKline [Research Triangle Park]
2 AP-HP - Hopital Saint-Louis [AP-HP]
3 MSSM - Icahn School of Medicine at Mount Sinai [New York]
4 YSM - Yale School of Medicine [New Haven, Connecticut]
5 IRCCS Ospedale San Raffaele [Milan, Italy]
6 CHU Tenon [AP-HP]
7 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
8 GSK - GlaxoSmithKline [Research Triangle Park]
Melanie Thompson
- Function : Author
Isabel Cassetti
- Function : Author
Marcelo Martins
- Function : Author
Moti Ramgopal
- Function : Author
Eduardo Sprinz
- Function : Author
Sandra Treviño-Pérez
- Function : Author
Adrian Streinu-Cercel
- Function : Author
Gulam H. Latiff
- Function : Author
Princy N. Kumar
- Function : Author